1	Conjunctival	conjunctival	JJ	JJ	_	2	amod	_	_
2	scarring	scarring	NN	NN	_	6	nsubjpass	_	_
3	in	in	IN	IN	_	2	prep	_	_
4	trachoma	trachoma	NN	NN	_	3	pobj	_	_
5	is	be	VBZ	VBZ	_	6	auxpass	_	_
6	associated	associate	VBN	VBN	_	0	ROOT	_	_
7	with	with	IN	IN	_	6	prep	_	_
8	the	the	DT	DT	_	10	det	_	_
9	HLA-C	hla-c	NN	NN	_	10	nn	_	_
10	ligand	ligand	NN	NN	_	7	pobj	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	KIR	kir	NN	NN	_	11	pobj	_	_
13	and	and	CC	CC	_	6	cc	_	_
14	is	be	VBZ	VBZ	_	15	auxpass	_	_
15	exacerbated	exacerbate	VBN	VBN	_	6	conj	_	_
16	by	by	IN	IN	_	15	prep	_	_
17	heterozygosity	heterozygosity	NN	NN	_	16	pobj	_	_
18	at	at	IN	IN	_	17	prep	_	_
19	KIR2DL2/KIR2DL3	kir2dl2/kir2dl3	NN	NN	_	18	pobj	_	_
20	.	.	.	.	_	6	punct	_	_

1	Chlamydia	chlamydia	NN	NN	_	2	nn	_	_
2	trachomatis	trachomatis	NN	NN	_	8	nsubj	_	_
3	is	be	VBZ	VBZ	_	8	cop	_	_
4	globally	globally	RB	RB	_	8	advmod	_	_
5	the	the	DT	DT	_	8	det	_	_
6	predominant	predominant	JJ	JJ	_	8	amod	_	_
7	infectious	infectious	JJ	JJ	_	8	amod	_	_
8	cause	cause	NN	NN	_	0	ROOT	_	_
9	of	of	IN	IN	_	8	prep	_	_
10	blindness	blindness	NN	NN	_	9	pobj	_	_
11	and	and	CC	CC	_	8	cc	_	_
12	one	one	CD	CD	_	8	conj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	the	the	DT	DT	_	18	det	_	_
15	most	most	RBS	RBS	_	16	advmod	_	_
16	common	common	JJ	JJ	_	18	amod	_	_
17	bacterial	bacterial	JJ	JJ	_	18	amod	_	_
18	causes	cause	NNS	NNS	_	13	pobj	_	_
19	of	of	IN	IN	_	18	prep	_	_
20	sexually	sexually	RB	RB	_	21	advmod	_	_
21	transmitted	transmit	VBN	VBN	_	22	amod	_	_
22	infection	infection	NN	NN	_	19	pobj	_	_
23	.	.	.	.	_	8	punct	_	_

1	Infections	infection	NNS	NNS	_	5	nsubj	_	_
2	of	of	IN	IN	_	1	prep	_	_
3	the	the	DT	DT	_	4	det	_	_
4	conjunctiva	conjunctiva	NN	NN	_	2	pobj	_	_
5	cause	cause	VB	VB	_	0	ROOT	_	_
6	the	the	DT	DT	_	9	det	_	_
7	blinding	blinding	JJ	JJ	_	9	amod	_	_
8	disease	disease	NN	NN	_	9	nn	_	_
9	trachoma	trachoma	NN	NN	_	5	dobj	_	_
10	,	,	,	,	_	9	punct	_	_
11	an	a	DT	DT	_	13	det	_	_
12	immuno-pathological	immuno-pathological	JJ	JJ	_	13	amod	_	_
13	disease	disease	NN	NN	_	9	appos	_	_
14	that	that	WDT	WDT	_	16	nsubjpass	_	_
15	is	be	VBZ	VBZ	_	16	auxpass	_	_
16	characterised	characterise	VBN	VBN	_	13	rcmod	_	_
17	by	by	IN	IN	_	16	prep	_	_
18	chronic	chronic	JJ	JJ	_	20	amod	_	_
19	conjunctival	conjunctival	JJ	JJ	_	20	amod	_	_
20	inflammation	inflammation	NN	NN	_	17	pobj	_	_
21	and	and	CC	CC	_	20	cc	_	_
22	fibrosis	fibrosis	NN	NN	_	20	conj	_	_
23	.	.	.	.	_	5	punct	_	_

1	The	the	DT	DT	_	5	det	_	_
2	polymorphic	polymorphic	JJ	JJ	_	5	amod	_	_
3	Killer-cell	killer-cell	NN	NN	_	5	nn	_	_
4	Immunoglobulin-like	immunoglobulin-like	JJ	JJ	_	5	amod	_	_
5	Receptors	receptor	NNS	NNS	_	10	nsubjpass	_	_
6	-LRB-	-lrb-	-LRB-	-LRB-	_	7	punct	_	_
7	KIR	kir	NN	NN	_	5	appos	_	_
8	-RRB-	-rrb-	-RRB-	-RRB-	_	7	punct	_	_
9	are	be	VBP	VBP	_	10	auxpass	_	_
10	found	find	VBN	VBN	_	0	ROOT	_	_
11	on	on	IN	IN	_	10	prep	_	_
12	Natural	natural	JJ	JJ	_	14	amod	_	_
13	Killer	killer	NN	NN	_	14	nn	_	_
14	cells	cell	NNS	NNS	_	11	pobj	_	_
15	and	and	CC	CC	_	10	cc	_	_
16	have	have	VBP	VBP	_	17	aux	_	_
17	co-evolved	co-evolve	VBN	VBN	_	10	conj	_	_
18	with	with	IN	IN	_	17	prep	_	_
19	the	the	DT	DT	_	22	det	_	_
20	Human	human	JJ	JJ	_	22	amod	_	_
21	Leucocyte	leucocyte	NN	NN	_	22	nn	_	_
22	Antigen	antigen	NN	NN	_	18	pobj	_	_
23	-LRB-	-lrb-	-LRB-	-LRB-	_	28	punct	_	_
24	HLA	hla	NN	NN	_	28	nn	_	_
25	-RRB-	-rrb-	-RRB-	-RRB-	_	28	punct	_	_
26	class	class	NN	NN	_	28	nn	_	_
27	I	i	CD	CD	_	28	num	_	_
28	system	system	NN	NN	_	22	dep	_	_
29	.	.	.	.	_	10	punct	_	_

1	Certain	certain	JJ	JJ	_	3	amod	_	_
2	genetic	genetic	JJ	JJ	_	3	amod	_	_
3	constellations	constellation	NNS	NNS	_	12	nsubjpass	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	KIR	kir	NN	NN	_	4	pobj	_	_
6	and	and	CC	CC	_	5	cc	_	_
7	HLA	hla	NN	NN	_	10	nn	_	_
8	class	class	NN	NN	_	10	nn	_	_
9	I	i	CD	CD	_	10	num	_	_
10	polymorphisms	polymorphism	NNS	NNS	_	5	conj	_	_
11	are	be	VBP	VBP	_	12	auxpass	_	_
12	associated	associate	VBN	VBN	_	0	ROOT	_	_
13	with	with	IN	IN	_	12	prep	_	_
14	a	a	DT	DT	_	15	det	_	_
15	number	number	NN	NN	_	13	pobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	diseases	disease	NNS	NNS	_	16	pobj	_	_
18	in	in	IN	IN	_	32	prep	_	_
19	which	which	WDT	WDT	_	18	pobj	_	_
20	modulation	modulation	NN	NN	_	32	nsubj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	the	the	DT	DT	_	24	det	_	_
23	innate	innate	JJ	JJ	_	24	amod	_	_
24	responses	response	NNS	NNS	_	21	pobj	_	_
25	to	to	TO	TO	_	24	prep	_	_
26	viral	viral	JJ	JJ	_	30	amod	_	_
27	and	and	CC	CC	_	26	cc	_	_
28	intracellular	intracellular	JJ	JJ	_	26	conj	_	_
29	bacterial	bacterial	JJ	JJ	_	30	amod	_	_
30	pathogens	pathogen	NNS	NNS	_	25	pobj	_	_
31	is	be	VBZ	VBZ	_	32	cop	_	_
32	central	central	JJ	JJ	_	17	rcmod	_	_
33	.	.	.	.	_	12	punct	_	_

1	A	a	DT	DT	_	2	det	_	_
2	sample	sample	NN	NN	_	22	nsubjpass	_	_
3	of	of	IN	IN	_	2	prep	_	_
4	134	134	CD	CD	_	6	num	_	_
5	Gambian	gambian	JJ	JJ	_	6	amod	_	_
6	pedigrees	pedigree	NNS	NNS	_	3	pobj	_	_
7	selected	select	VBN	VBN	_	6	vmod	_	_
8	to	to	TO	TO	_	9	aux	_	_
9	contain	contain	VB	VB	_	7	xcomp	_	_
10	at	at	IN	IN	_	12	quantmod	_	_
11	least	least	JJS	JJS	_	10	mwe	_	_
12	one	one	CD	CD	_	13	num	_	_
13	individual	individual	NN	NN	_	9	dobj	_	_
14	with	with	IN	IN	_	13	prep	_	_
15	conjunctival	conjunctival	JJ	JJ	_	16	amod	_	_
16	scarring	scarring	NN	NN	_	14	pobj	_	_
17	in	in	IN	IN	_	16	prep	_	_
18	the	the	DT	DT	_	20	det	_	_
19	F1	f1	NN	NN	_	20	nn	_	_
20	generation	generation	NN	NN	_	17	pobj	_	_
21	was	be	VBD	VBD	_	22	auxpass	_	_
22	used	use	VBN	VBN	_	0	ROOT	_	_
23	.	.	.	.	_	22	punct	_	_

1	Individuals	individual	NNS	NNS	_	8	nsubjpass	_	_
2	-LRB-	-lrb-	-LRB-	-LRB-	_	3	punct	_	_
3	n	n	NN	NN	_	1	dep	_	_
4	=	=	JJ	JJ	_	3	amod	_	_
5	830	830	CD	CD	_	4	dep	_	_
6	-RRB-	-rrb-	-RRB-	-RRB-	_	3	punct	_	_
7	were	be	VBD	VBD	_	8	auxpass	_	_
8	genotyped	genotype	VBN	VBN	_	0	ROOT	_	_
9	for	for	IN	IN	_	8	prep	_	_
10	HLA	hla	NN	NN	_	11	nn	_	_
11	class	class	NN	NN	_	9	pobj	_	_
12	I	i	CD	CD	_	11	num	_	_
13	and	and	CC	CC	_	11	cc	_	_
14	KIR	kir	NN	NN	_	16	nn	_	_
15	gene	gene	NN	NN	_	16	nn	_	_
16	families	family	NNS	NNS	_	11	conj	_	_
17	.	.	.	.	_	8	punct	_	_

1	Family	Family	NNP	NNP	_	2	nsubj	_	_
2	Based	base	VBD	VBD	_	0	ROOT	_	_
3	Association	Association	NNP	NNP	_	4	nn	_	_
4	Tests	Tests	NNP	NNP	_	10	nsubjpass	_	_
5	and	and	CC	CC	_	4	cc	_	_
6	Case	Case	NNP	NNP	_	8	nn	_	_
7	Pseudo-control	pseudo-control	JJ	JJ	_	8	amod	_	_
8	tests	test	NNS	NNS	_	4	conj	_	_
9	were	be	VBD	VBD	_	10	auxpass	_	_
10	used	use	VBN	VBN	_	2	ccomp	_	_
11	to	to	TO	TO	_	12	aux	_	_
12	extend	extend	VB	VB	_	10	xcomp	_	_
13	tests	test	NNS	NNS	_	12	dobj	_	_
14	for	for	IN	IN	_	13	prep	_	_
15	transmission	transmission	NN	NN	_	16	nn	_	_
16	disequilibrium	disequilibrium	NN	NN	_	14	pobj	_	_
17	to	to	TO	TO	_	18	aux	_	_
18	take	take	VB	VB	_	12	vmod	_	_
19	full	full	JJ	JJ	_	20	amod	_	_
20	advantage	advantage	NN	NN	_	18	dobj	_	_
21	of	of	IN	IN	_	20	prep	_	_
22	the	the	DT	DT	_	24	det	_	_
23	family	family	NN	NN	_	24	nn	_	_
24	design	design	NN	NN	_	21	pobj	_	_
25	,	,	,	,	_	12	punct	_	_
26	genetic	genetic	JJ	JJ	_	27	amod	_	_
27	model	model	NN	NN	_	12	dobj	_	_
28	and	and	CC	CC	_	27	cc	_	_
29	phenotype	phenotype	NN	NN	_	27	conj	_	_
30	.	.	.	.	_	2	punct	_	_

1	We	we	PRP	PRP	_	2	nsubj	_	_
2	found	find	VBD	VBD	_	0	ROOT	_	_
3	that	that	IN	IN	_	2	prep	_	_
4	the	the	DT	DT	_	5	det	_	_
5	odds	odds	NNS	NNS	_	3	pobj	_	_
6	of	of	IN	IN	_	5	prep	_	_
7	trachomatous	trachomatous	JJ	JJ	_	8	amod	_	_
8	scarring	scarring	NN	NN	_	6	pobj	_	_
9	increased	increase	VBN	VBN	_	5	vmod	_	_
10	with	with	IN	IN	_	9	prep	_	_
11	the	the	DT	DT	_	12	det	_	_
12	number	number	NN	NN	_	10	pobj	_	_
13	of	of	IN	IN	_	12	prep	_	_
14	genome	genome	NN	NN	_	15	nn	_	_
15	copies	copy	NNS	NNS	_	13	pobj	_	_
16	of	of	IN	IN	_	15	prep	_	_
17	HLA-C2	hla-c2	NN	NN	_	16	pobj	_	_
18	-LRB-	-lrb-	-LRB-	-LRB-	_	19	punct	_	_
19	C1/C2	c1/c2	NN	NN	_	17	dep	_	_
20	OR	or	NN	NN	_	19	dep	_	_
21	=	=	JJ	JJ	_	20	amod	_	_
22	2.29	2.29	CD	CD	_	23	num	_	_
23	BHP-value	bhp-value	NN	NN	_	21	dep	_	_
24	=	=	JJ	JJ	_	23	amod	_	_
25	0.006	0.006	CD	CD	_	24	dep	_	_
26	;	;	:	:	_	20	punct	_	_
27	C2/C2	c2/c2	NN	NN	_	20	dep	_	_
28	OR	or	NN	NN	_	27	dep	_	_
29	=	=	JJ	JJ	_	28	amod	_	_
30	3.97	3.97	CD	CD	_	31	num	_	_
31	BHP-value	bhp-value	NN	NN	_	32	nsubj	_	_
32	=	=	JJ	JJ	_	29	dep	_	_
33	0.0004	0.0004	CD	CD	_	32	dobj	_	_
34	-RRB-	-rrb-	-RRB-	-RRB-	_	27	punct	_	_
35	and	and	CC	CC	_	20	cc	_	_
36	further	further	RB	RB	_	37	advmod	_	_
37	increased	increase	VBD	VBD	_	20	conj	_	_
38	when	when	WRB	WRB	_	37	dep	_	_
39	both	both	DT	DT	_	40	preconj	_	_
40	KIR2DL2	kir2dl2	NN	NN	_	38	dep	_	_
41	and	and	CC	CC	_	40	cc	_	_
42	KIR2DL3	kir2dl3	NN	NN	_	53	npadvmod	_	_
43	-LRB-	-lrb-	-LRB-	-LRB-	_	53	punct	_	_
44	C2/C2	c2/c2	NN	NN	_	53	nsubj	_	_
45	OR	or	NN	NN	_	44	dep	_	_
46	=	=	JJ	JJ	_	45	amod	_	_
47	5.95	5.95	CD	CD	_	48	num	_	_
48	BHP-value	bhp-value	NN	NN	_	46	dep	_	_
49	=	=	JJ	JJ	_	48	amod	_	_
50	0.006	0.006	CD	CD	_	49	dep	_	_
51	-RRB-	-rrb-	-RRB-	-RRB-	_	45	punct	_	_
52	were	be	VBD	VBD	_	53	cop	_	_
53	present	present	JJ	JJ	_	40	conj	_	_
54	.	.	.	.	_	19	punct	_	_

1	To	to	TO	TO	_	2	aux	_	_
2	explain	explain	VB	VB	_	0	ROOT	_	_
3	the	the	DT	DT	_	4	det	_	_
4	observations	observation	NNS	NNS	_	2	dobj	_	_
5	in	in	IN	IN	_	4	prep	_	_
6	the	the	DT	DT	_	7	det	_	_
7	context	context	NN	NN	_	5	pobj	_	_
8	of	of	IN	IN	_	7	prep	_	_
9	chlamydial	chlamydial	JJ	JJ	_	10	amod	_	_
10	infection	infection	NN	NN	_	8	pobj	_	_
11	and	and	CC	CC	_	10	cc	_	_
12	trachoma	trachoma	NN	NN	_	10	conj	_	_
13	we	we	PRP	PRP	_	14	nsubj	_	_
14	propose	propose	VBP	VBP	_	2	parataxis	_	_
15	a	a	DT	DT	_	17	det	_	_
16	two-stage	two-stage	JJ	JJ	_	17	amod	_	_
17	model	model	NN	NN	_	14	dobj	_	_
18	of	of	IN	IN	_	17	prep	_	_
19	response	response	NN	NN	_	18	pobj	_	_
20	and	and	CC	CC	_	19	cc	_	_
21	disease	disease	NN	NN	_	19	conj	_	_
22	that	that	WDT	WDT	_	23	nsubj	_	_
23	balances	balance	VBZ	VBZ	_	17	rcmod	_	_
24	the	the	DT	DT	_	26	det	_	_
25	cytolytic	cytolytic	JJ	JJ	_	26	amod	_	_
26	response	response	NN	NN	_	23	dobj	_	_
27	of	of	IN	IN	_	26	prep	_	_
28	KIR	KIR	NNP	NNP	_	27	pobj	_	_
29	expressing	express	VBG	VBG	_	28	vmod	_	_
30	NK	nk	NN	NN	_	31	nn	_	_
31	cells	cell	NNS	NNS	_	29	dobj	_	_
32	with	with	IN	IN	_	29	prep	_	_
33	the	the	DT	DT	_	34	det	_	_
34	ability	ability	NN	NN	_	32	pobj	_	_
35	to	to	TO	TO	_	36	aux	_	_
36	secrete	secrete	VB	VB	_	34	vmod	_	_
37	interferon	interferon	NN	NN	_	38	nn	_	_
38	gamma	gamma	NN	NN	_	36	dobj	_	_
39	,	,	,	,	_	23	punct	_	_
40	a	a	DT	DT	_	41	det	_	_
41	combination	combination	NN	NN	_	23	dobj	_	_
42	that	that	WDT	WDT	_	44	nsubj	_	_
43	may	may	MD	MD	_	44	aux	_	_
44	cause	cause	VB	VB	_	41	rcmod	_	_
45	pathology	pathology	NN	NN	_	44	dobj	_	_
46	.	.	.	.	_	2	punct	_	_

1	The	the	DT	DT	_	2	det	_	_
2	data	datum	NNS	NNS	_	3	nsubj	_	_
3	presented	present	VBD	VBD	_	0	ROOT	_	_
4	indicate	indicate	VBP	VBP	_	3	dep	_	_
5	that	that	IN	IN	_	10	mark	_	_
6	HLA-C	hla-c	NN	NN	_	7	nn	_	_
7	genotypes	genotype	NNS	NNS	_	10	nsubj	_	_
8	are	be	VBP	VBP	_	10	cop	_	_
9	important	important	JJ	JJ	_	10	amod	_	_
10	determinants	determinant	NNS	NNS	_	4	ccomp	_	_
11	of	of	IN	IN	_	10	prep	_	_
12	conjunctival	conjunctival	JJ	JJ	_	13	amod	_	_
13	scarring	scarring	NN	NN	_	11	pobj	_	_
14	in	in	IN	IN	_	10	prep	_	_
15	trachoma	trachoma	NN	NN	_	14	pobj	_	_
16	and	and	CC	CC	_	10	cc	_	_
17	that	that	IN	IN	_	22	mark	_	_
18	KIR2DL2/KIR2DL3	kir2dl2/kir2dl3	NN	NN	_	19	nn	_	_
19	heterozygosity	heterozygosity	NN	NN	_	22	nsubj	_	_
20	further	further	JJ	JJ	_	22	amod	_	_
21	increases	increase	NNS	NNS	_	22	nn	_	_
22	risk	risk	NN	NN	_	10	conj	_	_
23	of	of	IN	IN	_	22	prep	_	_
24	conjunctival	conjunctival	JJ	JJ	_	25	amod	_	_
25	scarring	scarring	NN	NN	_	23	pobj	_	_
26	in	in	IN	IN	_	22	prep	_	_
27	individuals	individual	NNS	NNS	_	26	pobj	_	_
28	carrying	carry	VBG	VBG	_	27	vmod	_	_
29	HLA-C2	hla-c2	NN	NN	_	28	dobj	_	_
30	.	.	.	.	_	3	punct	_	_
